McKesson launches InspiroGene by McKesson, a dedicated business focused solely on supporting the commercialization of cell ...

AI software platform provider for transforming planning and decision-making, today announced the winners of its inaugural Partner Awards 2024. The o9 Partner Awards 2024 highlights these partners' ...

IMPACT trial is evaluating the safety and efficacy of pemvidutide in approximately 190 subjects with MASH; top-line efficacy data expected in Q2 ...

Chiesi’s strategy aligns with EU priorities on innovation, security, and private R&D investment: the decision to establish a ...

Fresenius Kabi, an operating company of Fresenius, specializing in biopharmaceuticals, clinical nutrition, medical technologies, and I.V. generic drugs for critical and chronic conditions, and ...

It is not the strongest of the species that survives, nor the most intelligent, but the one most responsive to change.” – ...

Formycon and Fresenius Kabi receive FDA approval for FYB202/ OtulfiTM (ustekinumab-aauz) Otulfi TM received FDA approval for both subcutaneous and intravenous formulations, to treat the same ...

Artificial intelligence (AI) is rapidly reshaping the landscape of innovation across industries. As businesses worldwide ...

INSIDE INFORMATION 30 September 2024, 23:55 CESTSequana Medical announces H1 2024 results and provides business update alfapump® - US FDA approval anticipated Q1 2025 and US launch planned for H2 2025 ...

The following is a round-up of earnings for London-listed companies, issued on Monday and not separately reported by Alliance News: Brighton Pier Group PLC - leisure and entertainment business that ...

New Delhi, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The global glass like carbon market is projected to hit the market valuation of US$ 133.89 million by 2032, up from US$ 89.26 million in 2023 at a CAGR of ...